Trial Profile
Long-Term Treatment with Tocilizumab (TCZ) in Biologic-naïve Patients with Rheumatoid Arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 27 Aug 2015 New trial record